The young founder teaching big pharma a new way to reverse aging
LEVITY - 21-Nov-2025Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
Join the club for FREE to access the whole archive and other member benefits.
Targeted epigenetic editing could deliver durable, precise therapies for aging-related diseases
New Hevolution–Nanobiosym deal accelerates AI-driven metabolic and ageing diagnostics
A widower’s new relationship after cryopreserving his wife ignites a fierce ethical debate in China
Boosting telomerase with engineered RNA reduced ageing and fibrosis in human lung tissue
Ageing clocks reveal 27% more drug targets, speeding multi-disease therapy
Walking performance in non-diabetic PAD patients remained unchanged despite metformin treatment
A centuries-old Greenland shark reveals how slow life in the deep sea fuels extreme longevity
AbbVie ends its $1.75B Calico deal after the ALS drug fosigotifator failed in phase 2/3 trials
The company hopes to begin human testing in the next few years
Insilico’s AI cut drug discovery to 18 months, spurring Lilly’s investment
Graphene-based BCIs use Azure AI to adapt in real time for Parkinson’s and stroke therapy
Low-dose antibiotics trigger microbes to make metabolites that improve longevity and metabolism
CRISPR therapy cut LDL and triglycerides by roughly 50% after a single infusion
Where scientists, startups, and self-experimenters converge on one question—how far can ageing really be pushed back?
Funding accelerates Stentrode’s clinical progress and hands-free device control for paralysis
Biohub will invest ~$1B a year to build AI-driven virtual cells and speed disease research
Nottingham scientists develop a protein-based gel that repairs and regenerates damaged teeth
New iPSC heart patch restores function in preclinical tests without open-heart surgery
Aging emerges when cells lose shared goals—but restoring those signals can trigger rejuvenation
Liverpool researchers found healthier habits could prevent or delay over 5 million years of illness
Study finds SENS seeks to reverse ageing, while Hallmarks model focuses on extending healthspan
$2B deal aims to develop AI-guided shuttles to carry therapies across the blood-brain barrier
5,000 deprived Scots to trial new obesity drugs in Glasgow
Centenarians delay disease ~30 years, showing aging can be slowed and health extended
Patients saw a 57% drop in heart failure and 78% fewer readmissions after stem cell therapy